Clinical predictor of survival following docetaxel-based chemotherapy

Prostate cancer (PCa) is the most common type of cancer in males in the USA and the incidence is increasing. For castration-resistant PCa (CRPC), previous studies have identified docetaxel-based chemotherapy as the first-line therapy. In the present study, the efficacy of docetaxel-based chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: LEE, HSIANG-YING, WU, WEN-JENG, HUANG, CHUN-HSIUNG, CHOU, YII-HER, HUANG, CHUN-NUNG, LEE, YUNG-CHIN, YANG, KAI-FU, LEE, MEI-HUI, HUANG, SHU-PIN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156217/
https://www.ncbi.nlm.nih.gov/pubmed/25202411
http://dx.doi.org/10.3892/ol.2014.2349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156217/
https://www.ncbi.nlm.nih.gov/pubmed/25202411
http://dx.doi.org/10.3892/ol.2014.2349

Ejemplares similares